Hydrea
Hydrea is a oncology medication containing Hydroxycarbamide, available as 500mg tablets.
- Category
- Oncology
- Active ingredient
- Hydroxycarbamide
- Route
- Oral use
- Form
- Capsule, hard
- Strengths
- 500mg
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Hydrea vary by country.
Details
- Conditions
- Chronic myeloid leukaemia · Polycythaemia vera · Essential thrombocythaemia · Sickle cell anaemia
- Therapeutic Class
- Antineoplastic Agent
- Pharmacological Class
- Antimetabolite
- Minor Side Effects
- nausea, fatigue, diarrhoea
- Moderate Side Effects
- leukopenia, stomatitis, skin ulceration
- Dosage Forms
- Capsule, hard
- Administration Route
- Oral use
- Prescription Status
- Prescription medicine
- Originator
- BMS
- Onset Time
- 1–2 weeks
- Duration
- long-term
- Storage Instructions
- Store in a cool, dry place.
- Drug Interactions
- Didanosine, Stavudine
- Age Restrictions
- Use in children managed by specialists.
What you will receive
Hydrea is the originator brand name, made by BMS. We use it here to identify the medicine only; we are not affiliated with BMS and do not ship the original Hydrea.
- You receive a generic equivalent: the same active ingredient (Hydroxycarbamide) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.